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Background: Copeptin is a protein that is released when the body experiences endogenic stress.  The level of copeptin elevated 
very early and slowly decreases in myocardial infarction. 
Aim: to determine the incremental value of combination copeptin and troponin T for early diagnosis of Acute Myocardial 
Infarction.
Methods: A search was conducted on PubMed and Cochrane. After screening title and abstract using inclusion and exclusion 
criteria, three articles were available as full text, but only 2 articles were considered useful by authors and were appraised based 
on its validity, importance and applicability. The other one article was excluded because the outcome of the study basically 
differentiates ACS and cardiomyopathy.  
Results: Both articles showthat the diagnostic value results are not so different. From the first article, a combination of copeptin 
and troponin T gives the results of sensitivity 87.4%, specificity 66.2%, PPV 46.9%, NPV 93.9%, pre-test probability 21.5%, 
post-test probability 40.8%, and AUC 0.91. The second article showed a combination of both gave sensitivity values of 98.8%, 
specificity 77.1%, PPV 46.2%, NPV 99.7%, pre-test probability 16.67%, and post-test probability 46.29%, and AUC 0,97. 
Conclusion: the combination of troponin T increase the sensitivity of diagnosis of AMI among patients suspected with acute 
coronary syndrome compared to troponin T alone. The combination of both can be considered as a test to diagnose AMI at 
early hours.
(J Kardiol Indones. 2011;32:113-7)
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Clinical Scenario
Fifty eight years old man was admitted to the hospital 
with chest pain since 3 hours before admission. He 
also had symptoms of shortness of breath, weakness, 
dizziness, palpitations, cold perspiration. 
From the physical examination, BP: 150/90, tem-
perature 360C, HR: 110x, RR: 34x. Chest examination 
revealed no abnormality. ECG showed ST depression 
at lead II, III, aVF.
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To confirm the diagnosis, the doctor needed to 
check the cardiac enzyme, but he was unsure whether 
the level of Troponin T was sufficient to be detected. 
One of his co-worker, suggest him to try to check for 
the Copeptin instead.
Introduction
Acute coronary syndrome (ACS) refers to a spectrum 
of clinical presentation ranging from unstable angina 
pectoris (UAP), non-ST segment elevation myocar-
dial infarction (NSTEMI), and ST segment elevation 
myocardial infarction (STEMI). Diagnosis of acute 
myocardial infarction (AMI)confirmed by a finding 
of the typical rise and fall of biochemical markers of 
myocardial necrosis coupled with one of the follow-
ing findings: ischemic symptoms, development of 
pathologic Q waves, ischemic ST-segment changes on 
electrocardiogram (ECG) or in the setting of a coronary 
intervention.1Troponin is the biomarker of choice for 
the detection of cardiac injury. Cardiac troponin level 
begins to rise at 4–6 hours after the onset of symptoms 
and the peak value occur at 18–24 hours after the onset 
of the symptom.2  Considering the necessity to conduct 
an early diagnosis in patient with ACS, several studies 
have been developed to find the role of copeptin in 
diagnosing ACS. Copeptin is the C-terminal part of 
pro-Agrinin Vasopressin andis released together with 
Agrinin Vasopressin (AVP) and it is released when body 
experiences endogenic stress such as myocardial infarc-
tion. Copeptin elevated very early (0 to 4 hours) after 
the onset of AMI symptom and slowly decrease after 
that.3However, researches are still needed to study the 
diagnostic value of copeptin in diagnosing AMI.
Clinical Question
In adult patient with suspected Acute Coronary 
Syndrome, can Copeptin combined with Troponin T 
establish early diagnosis of AMI? 
Methods
Search Strategy
Pubmed and Cochrane search was performed on30th 
May 2011. We used term “copeptin” and in refining 
order we used terms “troponin T” and “myocardial 
infarction” (Table 1).
Selection Criteria
After filtering using Boolean operator and MESH 
Terms, the first selection was based on title and abstract 
using inclusion and exclusion criteria. All diagnostic 
studies were included, while the studies using high-
sensitive troponin T and prognostic study are excluded. 
After reading the full text, one article was excluded 
because the outcome of the study basically differenti-
ates ACS and cardiomyopathy.  
Result
All appraised articles are cohort prospective studies 
conducted in Germany. Till Keller et al studied 1386 
consecutive patients came with chest pain symptom, 
806 of which were admitted to the hospital within 6 
hours onset. Of the 806 patients, 175 were diagnosed 
AMI, while the remainder were diagnosed UAP and 
non-coronary chest pain.All patients underwent co-
peptin andtroponin Texamination. Level of troponin 
Twas considered significant if >0.03 ng/ml and for 
copeptin if > 9.8 pmol/l. Examination of troponin T 
alone gave sensitivity values  of 50%, specificity 97.7%, 
PPV 87.9%, NPV 85.3%, pre-test probability 21.5%, 
post-test probability 85.4%, and AUC 0, 8. Copeptin 
examination alone gave sensitivity value of 74.9%, 
specificity 7.6%, PPV 44%, NPV 88.8%, pre-test 
probability 21.5%, post-test probability of 38.2%, and 
AUC 0.78,meanwhile, a combination of both gives 
the results of sensitivity 87.4%, specificity 66.2%, 
PPV 46.9%, NPV 93.9%, pre-test probability 21.5%, 
Table 1. Search strategy used in Pubmed and Cochrane, conducted on 30th May 2011
Engine Search Terms Result
Pubmed copeptin[All Fields] AND (“troponin T”[MeSH Terms] OR “troponin T”[All Fields]) AND 
(“myocardial infarction”[MeSH Terms] OR (“myocardial”[All Fields] AND “infarction”[All 
Fields]) OR “myocardial infarction”[All Fields])
5
Cochrane “copeptin” AND “troponin T” AND “myocardial infarction” 1
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Table 2.Critical appraisal of useful articles based on its validity, importancy, relevance and applicability
Articles
Criterion
Copeptin Improves Early Diagnosis 
of Acute Myocardial Infarction
Till Keller, et al.
Incremental Value of Copeptin for 
Rapid Rule Out of Acute Myocardial 
Infarction






Was there and Independent, blind compari-
son with a reference standard of diagnosis?
Yes Yes
Was the diagnostic test evaluated in an ap-
propriate spectrum of patients?
Yes Yes
Was the reference standard applied regardless 
of the diagnostic test result?
Yes Yes
Figure 1.Flow chart of conducted search
Jurnal Kardiologi Indonesia  
116 Jurnal Kardiologi Indonesia •  Vol. 32, No. 2 • April - Juni 2011
Articles
Criterion
Copeptin Improves Early Diagnosis 
of Acute Myocardial Infarction
Till Keller, et al.
Incremental Value of Copeptin for 
Rapid Rule Out of Acute Myocardial 
Infarction






Combination of Copeptina and 
Troponin Tb




Positive Predictive Value 46,9% 46,2%
Negative Predictive Value 93,9% 99,7%
Likelihood ratio (positive result) 2,57 4,31
Likelihood ratio (negative result) 0,19 0,02
Pre-test probability 21,5% 16,67%








Patients 48-75 years old with chest pain 
onset <6 hours
Patients 45-79 years old with chest pain 
onset <12 hours
Determinant
Troponin T, Copeptin, Myoglobin, 
CKMB, NT-ProBNP, and combina-
tion
Troponin T, Copeptin, and Combina-
tion
Comparison





Criteria for acute myocardial infarc-
tion:
Symptom of myocardial ischemia•	
Rising/falling pattern of serial Tro-•	
ponin T
Outcome
Added value of copeptin in early evalu-
ation of patients with suspected AMI
Increamental value of copeptin for 







Is the diagnostic test available, affordable, 
accurate, and precise in your setting?
No No
Can you generate a clinically sensible estimate 
of your patient’s pre-test probability?
Yes Yes
Will the resulting post-test probabilities affect 
your management and help your patient?
Yes Yes
Would the consequences of the test help 
your patient?
Yes Yes
aCopeptin level >9,8 pmol/l, bTroponin T level >0,03ng/ml, cCopeptin level >14 pmol/l, dTroponin T level >0,04ng/ml
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post-test probability 40.8%, and AUC 0.91.From these 
results, it can be concluded that the combination of 
troponin T and copeptin can increase the sensitivity up 
to 87.4% and NPV to 93.9%, with AUC 0.91.4
In the study conducted Tobias Rechlinet al, 487 
patients with chest pain onset less than 12 hours were 
included in this study and 81 of themwere diagnose-
das AMI. All patients were going through copeptin 
and troponin T examination, and in this study, level 
of copeptin was considered significant if >0.04ng/
ml and for copeptin if >14 pmol/l. This study did 
not give numbers of sensitivity and specificity of tro-
ponin T and copeptin examination separately, but a 
combination of both gave sensitivity values of 98.8%, 
specificity 77.1%, PPV 46.2%, NPV 99.7%, pre-test 
probability 16.67%, and post-test probability 46.29%. 
Nevertheless, Tobias et al compared the AUC of each 
examination. AUC for the examination of troponin T 
alone is 0.86, copeptin alone 0.75, and a combination 
of both increased the AUC to 0.97.5
Commentary
The appraisals of the articles above show that they 
have similar value in validity and results. However, 
they also have some points of strengths and weaknesses 
in each other.
Till Keller et al conducted a study with 1386 pa-
tients enrolled consecutively from January 2007 until 
July 2008. The researcher used such a large number 
of subjects that the results can determine the added 
value of copeptin in early diagnosis of AMI precisely. 
Furthermore, the characteristic of the patients in this 
study was similar to our patient. In this study, the pa-
tients’ mean age in this study was 61,5+13,4 and most 
of them are man (920 subjects), while our patient was 
included in, too. The chest pain onset (CPO) less than 
6 hours in this study was also similar to our clinical 
setting: 3 hours after onset of symptoms. 
Tobias Reichlin et al conducted a study with 487 
consecutive patients presenting to the Emergency 
Department. The characteristic of the patients in this 
study (mean age 62 + 17 and 321 male) was similar to 
our patient. However, the CPO studied in this article 
was less than 12 hours, which was quite different with 
our patient’s clinical setting. Compared with Till Keller 
et al, this study shows the Negative Predictive Value 
and Area under the ROC curves for the diagnosis of 
AMI higher.         
Overall, study by Till Keller convincingly con-
cluded that the combination of copeptin and troponin 
T improves early diagnosis of AMI in a large number of 
patients suspected with Acute Coronary Syndrome.
Conclusions and Recommendations
From all of researches, it can be concluded that the 
combination of troponin T and copeptinsignificantly 
improve early diagnosis of AMI. That combination 
increase the sensitivity of diagnosis of AMI among 
patients suspected with acute coronary syndrome 
compared to troponin T or copeptin alone. Although 
copeptin examination not yet available in Indonesia, 
we recommend the provision of copeptin examination 
and we also suggest the utilization of this combina-
tion in everyday practice for patients with early onset 
chest pain because based on researches, combination of 
copeptin and troponin T are very beneficial for diag-
nosing AMI at early hours. Early diagnosis is hopefully 
lead to a more appropriate patient management for 
AMI so that the mortality rates can be reduced.
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